Medical device benefit-risk analysis is a structured evaluation of whether the clinical benefits of a device outweigh its residual risks. It is mandated under ISO 14971:2019, FDA regulations, and EU MDR. Thus, it is critical for regulatory approval, patient safety,...
FDA design and development planning is a structured process mandated under 21 CFR Part 820 (Quality System Regulation). It serves as the mandated roadmap for controlling a medical device’s progression from initial concept to a validated product. It ensures...
Medical device development is a structured and highly regulated process. It takes a product from concept through design, testing, regulatory approval, and post-market monitoring to ensure safety, effectiveness, and compliance. It involves multiple phases, each with...
Design control for medical devices is a structured regulatory-mandated process. It ensures medical devices are designed to be safe, effective, and meet user needs before they reach the market. It is required under FDA’s 21 CFR, ISO 13485:2016, and indirectly under EU...
The CDSCO SUGAM portal is India’s official online platform for regulatory submissions to the Central Drugs Standard Control Organization (CDSCO). It allows manufacturers, importers, and researchers to apply for approvals related to drugs, medical devices, cosmetics,...
In the healthcare industry, ECG machines play a pivotal role by enabling early detection and monitoring of cardiovascular conditions. They provide accurate insights into heart rhythm and electrical activity. Hence, they support clinical decision-making in hospitals,...